1.
Maintenance of Response With Guselkumab for up to 3 Years’ Treatment in the Phase 3 VOYAGE 1 Trial of Patients With Plaque Psoriasis. J of Skin [Internet]. 2018 Dec. 17 [cited 2025 Apr. 19];2:S90. Available from: https://skin.dermsquared.com/skin/article/view/487